Telomerase and cancer stem cells

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 70, Issue , 2005, Pages 205-208

  Armanios, M ^a   Greider, C W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC; BETA CATENIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; WNT1 PROTEIN;

APLASTIC ANEMIA; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CONFERENCE PAPER; DYSKERATOSIS CONGENITA; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HYPERPIGMENTATION; HYPOTHESIS; LEUKOPLAKIA; NAIL DYSTROPHY; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANCER STAGING; DYSKERATOSIS; GENE OVEREXPRESSION; GENE SILENCING; MYELOID LEUKEMIA; NEOPLASM; ONCOGENE; PHENOTYPE; SQUAMOUS CELL CARCINOMA; TELOMERE SHORTENING; TUMOR SUPPRESSOR GENE; UPREGULATION;

DYSKERATOSIS CONGENITA; ENZYME ACTIVATION; GENOMIC INSTABILITY; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; TELOMERASE; TUMOR STEM CELLS;

EID: 33746415153     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2005.70.030     Document Type: Conference Paper

References (45)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. 100: 3983.
2. Allsopp R.C., Morin G.B., Horner J.W., DePinho R., Harley C.B., and Weissman I.L. 2003. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat. Med. 9: 369.
3. Armanios M., Chen J.L., Chang Y.P., Brodsky R.A., Hawkins A., Griffin C.A., Eshleman J.R., Cohen A.R., Chakravarti A., Hamosh A., and Greider C.W. 2005. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl. Acad. Sci. 102: 15960.
4. Berman D.M., Karhadkar S.S., Maitra A., Montes De Oca R., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N., and Beachy P.A. 2003. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846.
5. Blasco M.A., Rizen M., Greider C.W., and Hanahan D. 1996. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet. 12: 200.
6. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., and Greider C.W. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25.
7. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349.
8. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., and Bacchetti S. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11: 1921.
9. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194.
10. Dokal I. 2000. Dyskeratosis congenita in all its forms. Br. J. Haematol. 110: 768.
11. Dokal I. and Vulliamy T. 2003. Dyskeratosis congenita: Its link to telomerase and aplastic anaemia. Blood Rev. 17: 217.
12. Feldser D.M., Hackett J.A., and Greider C.W. 2003. Telomere dysfunction and the initiation of genome instability. Nat. Rev. Cancer 3: 623.
13. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., and Yu J., et al. 1995. The RNA component of human telomerase. Science 269: 1236.
14. Greider C.W. 1996. Telomere length regulation. Annu. Rev. Biochem. 65: 337.
15. Greider C.W. and Blackburn E.H. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405.
16. _. 1987. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51: 887.
17. _. 1989. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331.
18. Guenechea G., Gan O.I., Dorrell C., and Dick J.E. 2001. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat. Immunol. 2: 75.
19. Hackett J.A. and Greider C.W. 2002. Balancing instability: Dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 21: 619.
20. Hao L.Y., Strong M.A., and Greider C.W. 2004. Phosphorylation of H2AX at short telomeres in T cells and fibroblasts. J. Biol. Chem. 279: 45148.
21. Hao L.-Y., Armanios M., Strong M.A., Karim B., Feldser D.M., Huso D., and Greider C.W. 2005. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123: 1121.
22. Harley C.B., Futcher A.B., and Greider C.W. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345: 458.
23. Hemann M.T., Strong M.A., Hao L.Y., and Greider C.W. 2001a. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107: 67.
24. Hemann M.T., Rudolph K.L., Strong M.A., DePinho R.A., Chin L., and Greider C.W. 2001b. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol. Biol. Cell 12: 2023.
25. Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., Isaacs J.T., Berman D.M., and Beachy P.A. 2004. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707.
26. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011.
27. Kolquist K.A., Ellisen L.W., Counter C.M., Meyerson M., Tan L.K., Weinberg R.A., Haber D.A., and Gerald W.L. 1998. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 19: 182.
28. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645.
29. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., II, Greider C.W., and DePinho R.A. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569.
30. Lin S.Y. and Elledge S.J. 2003. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113: 881.
31. Ly H., Calado R.T., Allard P., Baerlocher G.M., Lansdorp P.M., Young N.S., and Parslow T.G. 2005. Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood 105: 2332.
32. Meeker A.K., Hicks J.L., Iacobuzio-Donahue C.A., Montgomery E.A., Westra W.H., Chan T.Y., Ronnett B.M., and De Marzo A.M. 2004. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 10: 3317.
33. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787.
34. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955.
35. Pardal R., Clarke M.F., and Morrison S.J. 2003. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3: 895.
36. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105.
37. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. 2004. Identification of human brain tumour initiating cells. Nature 432: 396.
38. Taipale J. and Beachy P.A. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature 411: 349.
39. van Heek N.T., Meeker A.K., Kern S.E., Yeo C.J., Lillemoe K.D., Cameron J.L., Offerhaus G.J., Hicks J.L., Wilentz R.E., Goggins M.G., De Marzo A.M., Hruban R.H., and Maitra A. 2002. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am. J. Pathol. 161: 1541.
40. Vulliamy T., Marrone A., Dokal I., and Mason P.J. 2002. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359: 2168.
41. Vulliamy T., Marrone A., Szydlo R., Walne A., Mason P.J., and Dokal I. 2004. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36: 447.
42. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., and Dokal I. 2001. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413: 432.
43. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., and Baylin S.B. 2003. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422: 313.
44. Yamaguchi H., Calado R.T., Ly H., Kajigaya S., Baerlocher G.M., Chanock S.J., Lansdorp P.M., and Young N.S. 2005. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352: 1413.
45. Zhu Y., Tomlinson R.L., Lukowiak A.A., Terns R.M., and Terns M.P. 2004. Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol. Biol. Cell 15: 81.